At Modulus, we are making breakthrough discoveries in small-molecule targeted therapeutics by combining our three strengths: (1) our unique core biology insights; (2) our integrated drug discovery platform; and (3) our resulting pipeline of proprietary drug discovery programs.
We are focused on small-molecule therapeutics discovery to address unmet patient need. We are a virtually integrated drug discovery firm with strengths in evaluation / validation of target biologies, and pursuing proprietary and collaborative discovery programs. Our purpose is to efficiently discover novel clinical candidate molecules with superior and differentiated patient efficacy profiles and improved safety. We welcome partners who can help take our candidate molecules through clinical trials together to ultimately deliver new medicines to patients in need.